These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 11972592)

  • 1. H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects.
    Leurs R; Church MK; Taglialatela M
    Clin Exp Allergy; 2002 Apr; 32(4):489-98. PubMed ID: 11972592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the cardiac safety of second-generation antihistamines.
    Taglialatela M; Annunziato L
    Allergy; 2000; 55 Suppl 60():22-30. PubMed ID: 10887972
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessing the cardiac safety of ebastine. Epilogue.
    Roberts DJ
    Drug Saf; 1999; 21 Suppl 1():89-92. PubMed ID: 10597871
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of depolarization-induced [3H]noradrenaline release from SH-SY5Y human neuroblastoma cells by some second-generation H(1) receptor antagonists through blockade of store-operated Ca(2+) channels (SOCs).
    Taglialatela M; Secondo A; Fresi A; Rosati B; Pannaccione A; Castaldo P; Giorgio G; Wanke E; Annunziato L
    Biochem Pharmacol; 2001 Nov; 62(9):1229-38. PubMed ID: 11705456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac ion channels and antihistamines: possible mechanisms of cardiotoxicity.
    Taglialatela M; Castaldo P; Pannaccione A; Giorgio G; Genovese A; Marone G; Annunziato L
    Clin Exp Allergy; 1999 Jul; 29 Suppl 3():182-9. PubMed ID: 10444235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Of oocytes and runny noses.
    Rosen MR
    Circulation; 1996 Aug; 94(4):607-9. PubMed ID: 8772677
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of HERG1 K(+) channels by the novel second-generation antihistamine mizolastine.
    Taglialatela M; Pannaccione A; Castaldo P; Giorgio G; Annunziato L
    Br J Pharmacol; 2000 Nov; 131(6):1081-8. PubMed ID: 11082114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desloratadine inhibits constitutive and histamine-stimulated nuclear factor-kappaB activity consistent with inverse agonism at the histamine H1 Receptor.
    Wu RL; Anthes JC; Kreutner W; Harris AG; West RE
    Int Arch Allergy Immunol; 2004 Dec; 135(4):313-8. PubMed ID: 15564772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epinastine, a nonsedating histamine H1 receptor antagonist, has a negligible effect on HERG channel.
    Chachin M; Katayama Y; Yamada M; Horio Y; Ohmura T; Kitagawa H; Uchida S; Kurachi Y
    Eur J Pharmacol; 1999 Jun; 374(3):457-60. PubMed ID: 10422790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole.
    Suessbrich H; Waldegger S; Lang F; Busch AE
    FEBS Lett; 1996 Apr; 385(1-2):77-80. PubMed ID: 8641472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular profile of loratadine.
    Hey JA; Affrime M; Cobert B; Kreutner W; Cuss FM
    Clin Exp Allergy; 1999 Jul; 29 Suppl 3():197-9. PubMed ID: 10444237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antihistamine fexofenadine does not affect I(Kr) currents in a case report of drug-induced cardiac arrhythmia.
    Scherer CR; Lerche C; Decher N; Dennis AT; Maier P; Ficker E; Busch AE; Wollnik B; Steinmeyer K
    Br J Pharmacol; 2002 Nov; 137(6):892-900. PubMed ID: 12411421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine.
    Roy M; Dumaine R; Brown AM
    Circulation; 1996 Aug; 94(4):817-23. PubMed ID: 8772706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of HERG and Kv1.5 by ketoconazole.
    Dumaine R; Roy ML; Brown AM
    J Pharmacol Exp Ther; 1998 Aug; 286(2):727-35. PubMed ID: 9694927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inconstancy of the human heart.
    Miller C
    Nature; 1996 Feb; 379(6568):767-8. PubMed ID: 8587597
    [No Abstract]   [Full Text] [Related]  

  • 16. A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG.
    Rampe D; Roy ML; Dennis A; Brown AM
    FEBS Lett; 1997 Nov; 417(1):28-32. PubMed ID: 9395068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Famotidine does not induce long QT syndrome: experimental evidence from in vitro and in vivo test systems.
    Sugiyama A; Satoh Y; Takahara A; Nakamura Y; Shimizu-Sasamata M; Sato S; Miyata K; Hashimoto K
    Eur J Pharmacol; 2003 Apr; 466(1-2):137-46. PubMed ID: 12679150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biased agonism at histamine H
    Burghi V; Echeverría EB; Zappia CD; Díaz Nebreda A; Ripoll S; Gómez N; Shayo C; Davio CA; Monczor F; Fernández NC
    Eur J Pharmacol; 2021 Apr; 896():173913. PubMed ID: 33508282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive activity of the histamine H(1) receptor reveals inverse agonism of histamine H(1) receptor antagonists.
    Bakker RA; Wieland K; Timmerman H; Leurs R
    Eur J Pharmacol; 2000 Jan; 387(1):R5-7. PubMed ID: 10633171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872.
    Thomas D; Wendt-Nordahl G; Röckl K; Ficker E; Brown AM; Kiehn J
    J Pharmacol Exp Ther; 2001 May; 297(2):753-61. PubMed ID: 11303067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.